NCT02109484View on ClinicalTrials.gov

Phase I/II Descending Age Study of P2VP8 Subunit Parenteral Rotavirus Vaccine in Healthy Toddlers and Infants

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Evaluation of a Rotavirus Vaccine
Interventions
BIOLOGICAL

P2-VP8 Subunit Vaccine 10mcg

10 mcg

BIOLOGICAL

P2-VP8 Subunit Vaccine 30 mcg

30 mcg

BIOLOGICAL

P2-VP8 Subunit Vaccine 60mcg

60 mcg

OTHER

Placebo

Trial Locations (1)

2013

Respiratory and Meningeal Pathogens Research Unit (RMPRU), Johannesburg

All Listed Sponsors
lead

PATH

OTHER

NCT02109484 - Phase I/II Descending Age Study of P2VP8 Subunit Parenteral Rotavirus Vaccine in Healthy Toddlers and Infants | Biotech Hunter | Biotech Hunter